Evidence map›Paper›PMID 29142291›Full record

ArticleScientific reports2017

Resveratrol modulates cocaine-induced inhibitory synaptic plasticity in VTA dopamine neurons by inhibiting phosphodiesterases (PDEs).

Yan Li, Laikang Yu, Li Zhao, Fanxing Zeng, Qing-Song Liu

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
0.7field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 26 citations in OpenAlex.

  1. Review
  2. Resveratrol, a calorie restriction mimetic, protects AlClNaunyn-Schmiedeberg's archives of pharmacology · 2025
    Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. An update on extra-oral bitter taste receptors.Journal of translational medicine · 2021
    Review
  9. Article
  10. Review
  11. Review
  12. Article
  13. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 2 countries.

Yan LiDepartment of Exercise Physiology, Beijing Sport University, Beijing, 100084, China.
Laikang YuDepartment of Exercise Physiology, Beijing Sport University, Beijing, 100084, China.
Li ZhaoDepartment of Exercise Physiology, Beijing Sport University, Beijing, 100084, China. zhaolispring@126.com.
Fanxing ZengDepartment of Exercise Physiology, Beijing Sport University, Beijing, 100084, China.
Qing-Song LiuDepartment of Pharmacology and Toxicology, Medical College of Wisconsin, 8701 Watertown Plank Road, Milwaukee, WI, 53226, USA. qsliu@mcw.edu.
Beijing Sport University · CNMedical College of Wisconsin · US

Funding

Mechanistic studies of phosphodiesterase inhibitors in cocaine addictionR01DA035217 · NIDA · MEDICAL COLLEGE OF WISCONSIN · PI LIU, QING-SONG · 2014 to 2023
$3.4M
NIDA NIH HHS R01 DA035217
6 · The paper itself

Abstract

Resveratrol is a natural phytoalexin synthesized by plants, including grapes. It displays a wide range of neuroprotective benefits associated with anti-aging. Recent studies have shown that resveratrol regulates dopaminergic transmission and behavioral effects of drugs of abuse. The goal of the present study is to investigate whether and how resveratrol alters basal inhibitory synaptic transmission and cocaine-induced inhibitory synaptic plasticity in dopamine neurons of the ventral tegmental area (VTA). We report that resveratrol elevated cAMP levels by itself and further potentiated a forskolin-induced increase in cAMP levels in midbrain slices, consistent with reported effects of inhibition of phosphodiesterases (PDEs). Resveratrol potentiated GABA

Indexed as

AgingAnimalsCocaineCocaine-Related DisordersCyclic AMPCyclic AMP-Dependent Protein KinasesDopaminergic NeuronsEndocannabinoidsGABAergic Neuronsgamma-Aminobutyric AcidHumansLong-Term Synaptic DepressionMiceNeuronal PlasticityNeuroprotective AgentsPhosphodiesterase InhibitorsCocaineCyclic AMPCyclic AMP-Dependent Protein KinasesEndocannabinoidsgamma-Aminobutyric AcidNeuroprotective AgentsPhosphodiesterase InhibitorsPhosphoric Diester HydrolasesResveratrol

Identifiers

PMID29142291
PMCPMC5688096
OpenAlexW2767693656

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.